Abstract
As artificial intelligence moves into the realm of clinical trials, consideration is needed on whether the current CONSORT and SPIRIT reporting statements are sufficient to ensure transparency. This commentary describes work by an international group of researchers who form the CONSORT-AI and SPIRIT-AI Steering Group to develop new reporting guidelines for AI-driven interventions in clinical trials.
Citation information
Liu, X., Rivera, S.C., Faes, L. et al. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat Med 25, 1467–1468 (2019) doi:10.1038/s41591-019-0603-3
Turing affiliated authors
Dr Sebastian Vollmer
Associate Professor, University of Warwick